Regulatory · source year

2006 regulatory records

16 selected, source-linked regulatory records dated 2006. This is selective source coverage, not a complete timeline.

Dated records

16 selected records.

Peptide profiles

11 connected profiles.

Cited sources

16 distinct public records.

Cited chronology

Dated source records

All record types in 2006 →

October 2006

3 records

Octreotide

Federal Register notice E6-17284

The Federal Register published notice E6-17284, attributed to FDA and its parent HHS department, on 2006-10-18. Its official title is “Summaries of Medical and Clinical Pharmacology Reviews of Pediatric Studies; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Source: Federal Register via GovInfo ↗

→

Nesiritide

Federal Register notice E6-16091

The Federal Register published notice E6-16091, attributed to FDA and its parent HHS department, on 2006-10-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; NATRECOR,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.

Source: Federal Register via GovInfo ↗

→

Exenatide

Federal Register notice E6-16086

The Federal Register published notice E6-16086, attributed to FDA and its parent HHS department, on 2006-10-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; BYETTA,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Source: Federal Register via GovInfo ↗

→

September 2006

1 record

Enfuvirtide

Federal Register notice E6-15554

The Federal Register published notice E6-15554, attributed to FDA and its parent HHS department, on 2006-09-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; FUZEON,” and PeptideScanner's exact reviewed identity mapping connects the document to Enfuvirtide.

Source: Federal Register via GovInfo ↗

→

August 2006

1 record

Mecasermin

Federal Register notice E6-12571

The Federal Register published notice E6-12571, attributed to FDA and its parent HHS department, on 2006-08-03. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IPLEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.

Source: Federal Register via GovInfo ↗

→

June 2006

5 records

Pramlintide

Federal Register notice E6-9414

The Federal Register published notice E6-9414, attributed to FDA and its parent HHS department, on 2006-06-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SYMLIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide.

Source: Federal Register via GovInfo ↗

→

Glucagon

Federal Register notice E6-9440

The Federal Register published notice E6-9440, attributed to FDA and its parent HHS department, on 2006-06-16. Its official title is “Merck & Co., Inc., et al.; Withdrawal of Approval of 65 New Drug Applications and 52 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Source: Federal Register via GovInfo ↗

→

Daptomycin

Federal Register notice E6-9225

The Federal Register published notice E6-9225, attributed to FDA and its parent HHS department, on 2006-06-14. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; CUBICIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

Source: Federal Register via GovInfo ↗

→

Mecasermin

Federal Register notice E6-9138

The Federal Register published notice E6-9138, attributed to FDA and its parent HHS department, on 2006-06-13. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; INCRELEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.

Source: Federal Register via GovInfo ↗

→

Cetrorelix

Federal Register notice E6-9031

The Federal Register published notice E6-9031, attributed to FDA and its parent HHS department, on 2006-06-09. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; CETROTIDE,” and PeptideScanner's exact reviewed identity mapping connects the document to Cetrorelix.

Source: Federal Register via GovInfo ↗

→

March 2006

2 records

Ziconotide

Federal Register notice E6-3712

The Federal Register published notice E6-3712, attributed to FDA and its parent HHS department, on 2006-03-15. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; PRIALT,” and PeptideScanner's exact reviewed identity mapping connects the document to Ziconotide.

Source: Federal Register via GovInfo ↗

→

February 2006

2 records

January 2006

2 records

Daptomycin

Federal Register notice E6-1069

The Federal Register published notice E6-1069, attributed to FDA and its parent HHS department, on 2006-01-30. Its official title is “Anti-Infective Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

Source: Federal Register via GovInfo ↗

→